Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium vivax | NADPH-cytochrome p450 reductase, putative | 0.00701865 | 0.026623 | 1 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.00701865 | 0.026623 | 0.5 |
Trypanosoma brucei | NADPH-dependent diflavin oxidoreductase 1 | 0.00701865 | 0.026623 | 0.5 |
Echinococcus granulosus | NADPH dependent diflavin oxidoreductase 1 | 0.00701865 | 0.026623 | 0.0216975 |
Echinococcus multilocularis | NADPH cytochrome P450 reductase | 0.00701865 | 0.026623 | 0.567043 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.00701865 | 0.026623 | 0.567043 |
Giardia lamblia | Hypothetical protein | 0.00643918 | 0.0215883 | 0.5 |
Leishmania major | NADPH-cytochrome p450 reductase-like protein | 0.00701865 | 0.026623 | 1 |
Plasmodium falciparum | nitric oxide synthase, putative | 0.00701865 | 0.026623 | 0.5 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.00701865 | 0.026623 | 0.5 |
Echinococcus granulosus | NADPH cytochrome P450 reductase | 0.00701865 | 0.026623 | 0.0216975 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.00701865 | 0.026623 | 0.5 |
Brugia malayi | flavodoxin family protein | 0.00701865 | 0.026623 | 1 |
Brugia malayi | FAD binding domain containing protein | 0.00701865 | 0.026623 | 1 |
Echinococcus granulosus | Solute carrier family 22 5 | 0.119048 | 1 | 1 |
Giardia lamblia | Nitric oxide synthase, inducible | 0.00643918 | 0.0215883 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.00701865 | 0.026623 | 0.567043 |
Trichomonas vaginalis | sulfite reductase, putative | 0.00701865 | 0.026623 | 1 |
Leishmania major | p450 reductase, putative | 0.00701865 | 0.026623 | 1 |
Schistosoma mansoni | biogenic amine (5HT) receptor | 0.00891577 | 0.0431064 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.00891577 | 0.0431064 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.00891577 | 0.0431064 | 1 |
Schistosoma mansoni | cytochrome P450 reductase | 0.00701865 | 0.026623 | 0.617612 |
Echinococcus multilocularis | serotonin receptor | 0.00891577 | 0.0431064 | 1 |
Schistosoma mansoni | 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase | 0.004534 | 0.00503479 | 0.116799 |
Trypanosoma cruzi | p450 reductase, putative | 0.00701865 | 0.026623 | 0.5 |
Trypanosoma cruzi | NADPH-dependent FMN/FAD containing oxidoreductase, putative | 0.00701865 | 0.026623 | 0.5 |
Echinococcus granulosus | biogenic amine 5HT receptor | 0.00891577 | 0.0431064 | 0.0382643 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.00701865 | 0.026623 | 0.5 |
Mycobacterium ulcerans | formate dehydrogenase H FdhF | 0.00701865 | 0.026623 | 0.5 |
Echinococcus multilocularis | NADPH dependent diflavin oxidoreductase 1 | 0.00701865 | 0.026623 | 0.567043 |
Trypanosoma brucei | NADPH-cytochrome p450 reductase, putative | 0.00701865 | 0.026623 | 0.5 |
Echinococcus multilocularis | serotonin receptor | 0.00891577 | 0.0431064 | 1 |
Chlamydia trachomatis | sulfite reductase | 0.004534 | 0.00503479 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | Antitrypanosomal activity against Trypanosoma cruzi Y infected in human LLC-MK2 cells after 24 hrs by MTT assay | ChEMBL. | 18177008 | |
IC50 (functional) | = 3 ug ml-1 | Cytotoxicity against human HCT8 cells | ChEMBL. | 18177008 |
IC50 (functional) | = 9.8 ug ml-1 | Cytotoxicity against human SF295 cells | ChEMBL. | 18177008 |
IC50 (functional) | = 10.4 ug ml-1 | Cytotoxicity against human MDA-MB-435 cells | ChEMBL. | 18177008 |
IC50 (functional) | = 13.3 ug ml-1 | Cytotoxicity against human HL60 cells | ChEMBL. | 18177008 |
IC50 (functional) | = 0.39 uM | Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 after 72 hrs by parasite LDH assay | ChEMBL. | 20521782 |
IC50 (functional) | = 0.39 uM | Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 after 72 hrs by lactate dehydrogenase assay | ChEMBL. | 25115700 |
IC50 (functional) | = 0.4 uM | Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 infected in human type A-positive red blood cells assessed as parasite lactate dehydrogenase activity after 72 hrs by spectrophotometric analysis | ChEMBL. | 22054038 |
IC50 (functional) | = 0.4 uM | Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 after 72 hrs by parasite lactate dehydrogenase assay | ChEMBL. | 24262380 |
IC50 (functional) | = 0.41 uM | Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 by pLDH assay | ChEMBL. | 17125261 |
IC50 (functional) | = 0.41 uM | Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 by pLDH assay | ChEMBL. | 17125261 |
IC50 (functional) | = 0.87 uM | Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D10 by pLDH assay | ChEMBL. | 17125261 |
IC50 (functional) | = 0.87 uM | Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D10 by pLDH assay | ChEMBL. | 17125261 |
IC50 (functional) | = 0.87 uM | Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D10 after 72 hrs by parasite LDH assay | ChEMBL. | 20521782 |
IC50 (functional) | = 0.9 uM | Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D10 infected in human type A-positive red blood cells assessed as parasite lactate dehydrogenase activity after 72 hrs by spectrophotometric analysis | ChEMBL. | 22054038 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | 17125261 | |
Homo sapiens | ChEMBL23 | 18177008 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.